chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pharmacist dispensed two vials of Moderna vaccine to Vaccine Center on 02/26/2022 at 08:17 AM. Both vials had the same Lot number  #070H21A , one had an expired beyond use date of 2/25/2022  and one had Beyond Use Date 03/02/2022. Each vial was dispensed in separate bag. Pharmacist notified the Vaccine Center of the error at 9:00 AM. Nurse pulled both vials from the bag and withdrew a booster dose from one of the vials and administer the booster to the patient at 08:51 AM on 02/26/2022.  Patient may have received the booster dose from the vials of expired beyond use date of 02/25/2022.
Is chest pain, exhaustion, fluttering in the heart, Passed out Admitted to the hospital for 7 days, they found low ejection fraction with myocarditis.
This is a spontaneous report from Non-Clinical-Study-Program Prevnar 13 Public Moms and Sandwich Generation Market Research from a contactable consumer (patients mother). A currently 7-months-old female started to received PREVNAR 13 via an unspecified route of administration on an unspecified date. The patient medical history and concomitant medications were not reported. Since turning 4 months old the patient had 3 ear infections and bronchitis twice on an unspecified date. Therapeutic measures were taken in response to the events were not reported. The patient recovered at the time of the report.   Follow-up (18FEB2014): Follow-up attempts completed. No further information expected.
Complained of dizziness, nausea, had small emesis, headache, shortness of breath, burning sensation on lips, skin on arms, chest, stomach. Taken to ER, Benadryl injection given. Diagnosis given as reaction to Hep B vaccine. Injection site in right deltoid without any redness, not hot to touch only slightly tender.
Shoulder Injury Related To Vaccine Administration ( SIRVA) Urgent care visit  Toradol Injection for pain  Aleve 2 tablets every 8 hours for pain Extreme Arm Pain Unable to lift or move arm (Frozen shoulder) Ice then heat packs
60% of body covered in red rash. Rash is warm to touch and not terribly itchy.; not terribly itchy; Rash is warm to touch; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0151) via an unspecified route of administration in the right arm on 08Apr2021 at 14:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia.  The patient previously first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6207) via an unspecified route of administration in the right arm on 18Mar2021 at 14:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included ibuprofen sodium (IBUPROFEN), gabapentin (MANUFACTURER UNKNOWN) and oxycodone (MANUFACTURER UNKNOWN) all from unknown date for unspecified indications. The patient was having allergy to keflex.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 08:30 the patient experienced "60% of body covered in red rash. Rash was warm to touch and not terribly itchy" as reported. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event(s). The clinical outcomes of the events red rash, warm to touch and not terribly itchy were not recovered.  No follow-up attempts are needed. No further information is expected.
immediately after receiving the vaccine, I began to experience numbness and tingling of my left arm. Within minutes, i began to feel numbness and tingling to my right arm. As some time passed, I also began to feel slight numbness and tingling to bilateral legs. I experienced the numbness and tingling for about 10 hours.
Red, hot, swollen of entire left deltoid which lasted 2-3 days after pneumovax. Continued with slight ache in left deltoid.
At 0922 this morning the member reported that he had a localized swelling on his right deltoid to an anthrax immunization which was given 2 days ago. The reaction has redness to the area and warm to the touch. Reported to coast guard medical officer for followup. Patient will be defered in the medical readiness reporting system from future anthrax immunizations.
ER 05/06/07 abnl x-ray abdomen; 05/7/07 Us abdomen 'findings highly suggestive of ileocolic intussusception. tx 'Air reduction.' 06/07/07-rcords received from facility for DOS 5/8-5/11/07-DC DX: Intussusception. One day history of emesis, nonbilious, nonbloody and multiple episodes of diarrhea with no blood no mucus. Refusing to eat. Seen in ER.
First shot no adverse effects. Second shot was EXTREMELY painful when given (it felt as though the needle broke off in my arm) and produced redness and stiff muscle followed by fever and increasing pain. The next day, and today 5 days later, the area is still red, painful,  and has developed small scabby blisters. I went back to the pharmacy today and was told to contact the center.
Redness/Erythema surrounding IM injection site, approx. 1" in diameter. Tenderness to touch.
He started having nervous tics, he had uncontrollable eye blinking and still does today.  This is neurological so there is a chance that the vaccine caused this neurological dysfunction.
Nausea and chills that started about 5 hours after vaccination; followed by joint pain. Ran a fever of 100 degrees at certain points in the night. Symptoms gone after 36 hours.
HARD TO BREATHE; DIZZY; RASH; NAUSEA; This spontaneous report received from a vaccine facility concerned a 52 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection, and concurrent conditions included uti diagnosis, alcohol use, non smoker, and loss of hearing in left ear, and other pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 09:45 on right arm for prophylactic vaccination. Concomitant medications included sulfamethoxazole/trimethoprim for uti. On MAR-2021, Laboratory data included: Blood pressure (NR: not provided) 136/76 mmHg, 168/95 mmHg, and Heart rate (NR: not provided) 127 BPM. On 18-MAR-2021, the subject experienced hard to breathe.  On 18-MAR-2021, the subject experienced dizzy. On 18-MAR-2021, the subject experienced rash. On 18-MAR-2021, the subject experienced nausea. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) 192/117 mmHg, and Heart rate (NR: not provided) 129 BPM. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from nausea, dizzy, and hard to breathe, and had not recovered from rash. This report was non-serious.
PT C/O WAKING UP WITH BAD MIGRAINE AND OCULAR AURA THIS MORNING, MAINLY IN RIGHT EYE, ALONG WITH SORENESS IN ARM WHERE VACCINATED; ALSO C/O EXTREME ITCHING IN HER FEET.
it was over 12 weeks to get the second dose and yesterday she said that they have given again the 1st dose; Diarrhea; Headache; My arm is sore; Tired and weakness; Tired and weakness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101016458.  A 35 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 06Aug2021 (Lot number: EW0187) at the age of 35 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 01, Lot no. EW0186), administration date: 05May2021, when the patient was 35 years old, reaction(s): "COVID-19 Immunization". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 06Aug2021, outcome "unknown", described as "it was over 12 weeks to get the second dose and yesterday she said that they have given again the 1st dose"; DIARRHOEA (non-serious) with onset Aug2021, outcome "unknown", described as "Diarrhea"; HEADACHE (non-serious) with onset Aug2021, outcome "unknown", described as "Headache"; PAIN IN EXTREMITY (non-serious) with onset Aug2021, outcome "unknown", described as "My arm is sore"; FATIGUE (non-serious), ASTHENIA (non-serious) all with onset Aug2021, outcome "unknown" and all described as "Tired and weakness". Therapeutic measures were not taken as a result of diarrhoea, headache, pain in extremity, fatigue, asthenia. Additional information: The patient reported that she already got the first dose of Pfizer Covid-19 Vaccine last 5May2021. However upon having appointment for the second dose on 06Aug2021 the patient received another first dose because it's been about 12 weeks since the first dose, that's why this patient wanted to ask because she was advised that it passed 4 weeks, so they administered another first dose for her. The patient wanted to know if it was ok to do so. The patient abruptly hung up the call. Product details (LOT, expiration date, NDC and UPC) and Pharmacy details could not be probed over the call. Limited information available over the call and appropriate response could not be provided. No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. Concurrent conditions and medical history were not reported. The pharmacist reported that on an unknown date in 2007, the patient may had received a dose of ZOSTAVAX (Lot number, expiration date, dose and route were not provided). Concomitant medication was not reported. Recently, on an unknown date, the patient was diagnosed with prostate cancer and was being treated with finasteride (manufacturer unknown) dose unspecified (MARRS#1604USA005910). The outcome of prostate cancer was unknown at the time of the report. The reporter did not assess the relatedness between ZOSTAVAX and prostate cancer. Upon internal review prostate cancer was considered a medically significant event. This is one of two reports from the same patient. Additional information has been requested.
had one dose a year ago can I now take second?; This case was reported by a consumer interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.  Previously administered products included Shingrix (received 1st dose a year ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows The patient self-reported the case. The age group was not reported but was captured as an adult as per the vaccine indication. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule. At the time of reporting, the patient asked, could he/she took 2nd dose now.
pt recv vax & presented w/approx 12 pox scattered on the cheek & diaper area;
After receiving the vaccine two days ago, my son has been inconsolable off and on and not sleeping well along with a hives like rash that has appeared more and more over his body over the last two days since receiving the vaccine.  The rash is worse on his bottom and back.  He has isolated, small patches of this rash on his legs, feet, stomach, etc.
Developed a lump in her left arm, had sunburn feel and was hot to touch, red and swollen.  Painful to touch also.    Temperature was not checked.  MD was not notified.  She was advised to call him, but doctor was not available so she was advised to call the Department of public health.  She was contacted again by the nurse and the arm was feeling better.  Took tylenol ES and it did help ..  One week later she was feeling better and the lump was decreasing in the area of the injection.
after receiving the first dose, the patient's lymph nodes swell up and was painful; after receiving the first dose, the patient's lymph nodes swell up and was painful; This is a spontaneous report from a contactable pharmacist. A 60-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: Not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. Facility where the COVID vaccine administered was reported as doctor's office/urgent care. Medical history was none. The patient's concomitant medications were not reported. No known drug allergies. COVID prior vaccination was reported as no and not tested for COVID post vaccination. The patient after receiving the first dose, lymph nodes swell up and was painful on 07May2021. The patient was hospitalized for 25 days for the reported events. Patient went to his primary MD who recommended a scan and was told okay to get the second dose. Patient didn't get the scan but received 2nd dose per MD recommendation. The patient received unknown treatment for events. The outcome of the event was reported as not resolved.; Sender's Comments: As there is limited information in the case provided, the causal association between the event pain, lymphadenopathy and the suspect drug BNT162B2 cannot be excluded.  The impact of this report on the benefit-risk profile of the Pfizer product and on the conduct of the study is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202101075144 similar report from same reporter
Post vax, the patient went to a physician and was told she had "bites". It was reported that the "bug bites" kept reappearing. The bites are itchy. The patient is being treated with Aveeno to alleviate the itching. It was noted that the paitent has no fever, is acting fine, happy and acting herself. It was also noted that the patient had 4 lesions at the time, no blisters and they are not broken. The patient sought unspecified medical attention. FOLLOW-UP information received from a physician indicated that on approximatley 10/16/00, approximately 6 to 8 weeks after receiving Varivax SC on 08/18/00, the patient developed scattered, pruritic papules primarily on her extrmities. The patient recovered from her symptoms at the end of 10, 2000. An office evaluation concluded that the symptoms were likely secondary to insect bites. Additional information is not expected.
Annual flu shot. Had serious adverse reaction to shot. Did not seek medical help but did call my physician and report. Held off on going to emergency room and felt ok after 48 hours.
I had chills, fever around 100 degrees after the vaccine. In June 2022. I woke up with severe knee pain on the left side. 2 weeks later the pain developed. I developed leg pain arthritis After the 1st booster. I saw the doctor at the end of June who took x-rays and Cartlidge loss in both knees. I was given steroid shots and 2 weeks after; I was given 2 months of physical therapy. After therapy my symptoms got worse and more painful. I had my 2nd booster in October of 2022. Afterward I was getting a gel injection in my knees 3 times.  This treatment also did not work. My physician referred me to someone else. The Orthopedic surgeon I saw said the treatment would now work due to to much deterioration. My doctor ordered an MRI in October of 2022, and it showed a tear I am scheduled for knee replacement on May 10, 2023, for the right knee and my left is scheduled for June 21, 2023. I am also taking arthritis medication Meloxicam for my pain.
fever to 102F,  weakness, mild sore throat, sore eyes, arm soreness, nausea, sweating, lightheadedness, nasal congestion, all occurred the day after 2nd dose of Pfizer vaccine. By the next day, everything resolved except for fatigue and sore throat. The  day after that, everything had resolved.
This 73 year old female received the Covid shot on  3/2/21    and went to the ED and admitted on  3/25/21 with the following diagnoses listed below. R56.9 - Seizure  R56.9 - Unspecified convulsions N17.9 - Acute kidney failure, unspecified
approx 3 hrs p/vax pt began crying hysterically, couldn't be consoled, wouldn't eat; pt had a fever but MOC doesn't remember how high; MOC called MD who advised to give larger than nl doses of APAP;
Beginning day after vaccine: constant numbness/tingling sensations and hot/cold sensations throughout legs from knee to feet, with intermingled pain; same sensations of pain and numbness throughout arms and torso but less constantly. These constant sensations lasted about 2 weeks (January 20-February 1, 2022). After that time the frequency of sensations slowly decreased but intensity of pain has increased. From February 1, 2022 to present: painful pinching sensations throughout body (on arms, legs, torso, feet, joints, head) which occur randomly and without warning; approximately 2-8 sensations/hour. Occasional numbness on various parts of body.
Pt received MENVEO and approx. 5 min later felt dizzy, hot and faint. Pt was helped to a sitting position and given water. She was WNL again about 15 min post vaccine.
Broke out with shingles at the injection site. Treated with Famvir 500 mg tid for 7 days.
Neck Pain; Arm Pain; Shoulder Pain; Swelling of Arm and Underarm; Lump at vaccine site; Headache; Nausea; Feeling Cold; Exhaustion; Cough; This is a spontaneous report from a contactable consumer. A 73-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: ER8730) via an unspecified route of administration in the left arm on 22Mar2021 at 19.00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included Osteoporosis. Concomitant medications were not provided. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: EN6205) via an unspecified route of administration in the left arm on 02Mar2021 at 17.00 as a single dose for COVID-19 immunisation. The patient was not allergic to any medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID-19 vaccine. It was unknown if the patient received any other medications within 2 weeks prior to vaccination. On 23Mar2021, the patient experienced severe neck pain, severe arm pain, severe shoulder pain, moderate swelling of arm and underarm, moderate lump at vaccine site, severe headache, moderate nausea, severe cold feeling, severe exhaustion and moderate cough. Therapeutic measures were taken as a result of neck pain, pain in arm, shoulder pain, swelling arm, vaccination site lump, headache, nausea, feeling cold, exhaustion and cough and included ibuprofen.  The clinical outcome of neck pain, pain in arm, shoulder pain, swelling arm, vaccination site lump, headache, nausea, feeling cold, exhaustion and cough was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
patient had bone chilling chills,pain in her left arm for one week, very fatigued, achy felt like bad flu for 3 days
After administering Flu and Pneumonia vaccines, within the couple of minutes, patient felt severe pain on his back and both legs with redness and sweat on his face with no breathing problems. After calling 911 and short evaluation from EMT personnel, after 10-15 minutes he said that he feels much better and he can walk without the pain. No treatment was given to hm and he refused to go to the hospital.
Rec'd shingles vaccine 10/19/2012 came down with shingles 9 days later on 10/28/2012.
Body Aches; Fever; Chills; Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EN6205) at the age of 48 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: PREMPRO LOW DOSE oral. The following information was reported: PAIN (non-serious), outcome "unknown", described as "Body Aches"; PYREXIA (non-serious), outcome "unknown", described as "Fever"; CHILLS (non-serious), outcome "unknown"; FATIGUE (non-serious), outcome "unknown".  Additional information: Fever, Chills, Body Aches, Fatigue began approximately 12 hrs. post dose and continued for 12-16 hrs. This has happened after each of the vaccination doses.; Sender's Comments: Linked Report(s): PFIZER INC-202201358718 same patient/AE, different vaccine dose; PFIZER INC-202201359445 same patient/AE, different vaccine dose;
Discomfort at shot area for 48+ hrs; onset of minor flu like symptoms took effect 12 hours after shot and lasted over the next 48 hours.; Needed to take naps during this 48 hour period some dizziness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Apr2021 (Lot number: FR8734) at the age of 59 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Type-2 Diabetes milletus" (unspecified if ongoing); "Stage 1 Hypertension" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; METFORMIN; ATENOLOL; ATORVASTATIN. Vaccination history included: Bnt162b2 (covid vaccine details , product-COVID 19 , brand-Pfizer, lot unknown reason- Unable to locate or read the details, lot unknown-True, Administration Date-28Feb2021, Administration Time-08:15 AM, vaccine location=Right arm, Dose number-1, Shot 1: Minor discomfort at shot area loss of energy for 24 hours), administration date: 28Feb2021, when the patient was 59 years old, for Covid-19 immunization, reaction(s): "Minor discomfort at shot area loss of energy for 24 hours", "Minor discomfort at shot area loss of energy for 24 hours". The following information was reported: VACCINATION SITE DISCOMFORT (non-serious) with onset Apr2021, outcome "recovered" (Apr2021), described as "Discomfort at shot area for 48+ hrs"; INFLUENZA LIKE ILLNESS (non-serious) with onset Apr2021, outcome "recovered" (Apr2021), described as "onset of minor flu like symptoms took effect 12 hours after shot and lasted over the next 48 hours."; DIZZINESS (non-serious) with onset Apr2021, outcome "recovered" (Apr2021), described as "Needed to take naps during this 48 hour period some dizziness". Therapeutic measures were not taken as a result of vaccination site discomfort, influenza like illness, dizziness.  Additional information: Facility type vaccine-Health clinic/Administration Facility. Patient did not received any other vaccine in four weeks. Patient did not have covid prior to vaccination and had not tested for covid post vaccination. No known allergies.  No follow-up attempts are possible. No further information is expected.